420 with CNW — Scientists Link Marijuana Smoke at Home to Secondhand Exposure in Children

A recently published JAMA study explored the effects of home marijuana smoking on children’s exposure to secondhand marijuana smoke (SHCS). Researchers in the U.S. used urinary biomarkers to assess the levels of delta 9 THC and its metabolites in kids, aiming to measure the extent of exposure and show the importance of preventive actions to protect their health.

The study analyzed Project Fresh Air data, which included households in San Diego County with children under 14 and at least one tobacco smoker. Researchers combined air particle monitoring data with parental reports of marijuana use at home to assess the SHCS exposure.

THC and its metabolites, such as 11-nor-9-carboxy and 11-hydroxy-THCs, which are indicators of SHCS exposure, were detected in 275 urine samples.

The researchers employed a residualization technique to estimate in-home marijuana smoking by combining data on air particles with self-reported smoking episodes, controlling for other sources including tobacco and events that produce particulates around the house. Additionally, smoking events were tracked using air particle monitors, and their correlation with reported marijuana usage was assessed.

Additional data collected included air nicotine levels, household ventilation practices, parental education, and income. Logistic regression was applied to determine the likelihood of detectable TTE based on in-home marijuana use, while linear regression was used to quantify exposure in children.

The results revealed that children living in homes where marijuana was smoked inside were substantially more exposed to SHCS, as indicated by traces of THC biomarkers in the urine. Among the 275 participants’ urine samples, 27.3 percent showed measurable levels of cannabinoids.

Compared to households without marijuana use, those reporting in-home use had a five-fold higher likelihood of having children with detectable TTE. Furthermore, children were 2.5 times more likely to have detectable TTE levels for every daily marijuana smoking event.

Children below six years old were particularly at risk due to spending more time indoors. Sensitivity analyses confirmed the consistency of these findings across various measures of smoking events. While non-specific smoking events also contributed to exposure, self-reported in-home marijuana smoking was more directly associated with THC biomarker detection.

The study underscored the health risks of indoor marijuana smoking for children, highlighting the need for policies and measures to reduce SHCS exposure in homes. The researchers emphasized that limiting marijuana use indoors could significantly lower children’s exposure to dangerous chemicals and called for further studies to assess the long-term effects of such exposure.

This study highlights why industry actors like Tilray Brands Inc. (NASDAQ: TLRY) (TSX: TLRY) wish to see the substance federally legalized in the U.S. and other jurisdictions so that extensive research can be conducted and various steps, such as licensing consumption lounges, are taken to limit any risks that could result from people being restricted to only consuming marijuana in their homes.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Pesticides, Bacteria Found in Marijuana Available in Dutch Coffee Shops

An investigation into marijuana sold in Dutch semi-legal coffee stores has uncovered a range of contaminants, including pesticides, lead, and harmful bacteria. The Netherlands Institute of Mental Health and Addiction study was designed to find a “baseline” for contamination levels typically found in cannabis products.

The findings will guide a trial launching in April, where coffee shops in 10 municipalities will offer marijuana grown by licensed producers under strict contamination limits.

Researchers tested a hundred and five marijuana samples, including weed and resin, purchased randomly from various sellers. Approximately 20% of the samples were found to have microbiological breaches such as fungal residue or Staphylococcus aureus bacteria. Pesticides were detected in about one-third of the samples, while one hashish sample contained a lead concentration of 28.5 mg/kg—nearly six times higher than the permissible level for the upcoming trial.

While cannabis is widely perceived as legal in the Netherlands, the reality is more nuanced. Since 1976, a tolerance policy has allowed marijuana and hash sales in regulated “coffee stores,” but cultivating more than 5 plants remains illegal. Consequently, coffee shops are forced to procure their supplies from unregulated sources, which often involve criminal networks and raises concerns about product contamination and safety.

The controlled marijuana trial aims to eliminate reliance on the illicit market and ensure cleaner products. Ten approved growers who have passed criminal background checks will be licensed to sell marijuana to participating coffee shops. Four of these growers are ready to begin supplying cannabis products, which will undergo testing for contaminants such as micro-organisms, heavy metals, pesticides, and aflatoxins—dangerous toxins made by fungi.

The discovery of Staphylococcus aureus in some samples highlights the importance of proper hygiene during all stages of cannabis production, including cultivation, packaging, and distribution. However, Pieter Oomen, one of the study’s authors, emphasized that the study was exploratory and does not suggest that all marijuana products sold in the Netherlands are contaminated.

The researchers concluded that the health risks posed by contaminants are relatively minor compared to the overall impact of smoking cannabis, particularly when mixed with tobacco. “The effect of contaminants depends heavily on the immune system of the individual,” Oomen explained.

“The risks added by these contaminants are not likely to outweigh the inherent risks of marijuana use itself, which include addiction, anxiety, and impaired attention that can lead to accidents. If you want to avoid health risks entirely, the best choice is to abstain from drug use,” he added.

The findings of this baseline study make a strong case for the creation of a regulated marijuana market where licensed companies like SNDL Inc. (NASDAQ: SNDL) are allowed to mushroom and operate while adhering to strict product standards so that consumers are safeguarded from exposure to high levels of contaminants.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Nebraskan Lawmakers Consider Proposals to Implement Voter-Approved Medical Marijuana Program

Three pieces of legislation have been introduced in Nebraska aiming to implement medical marijuana legalization and regulation initiatives approved by voters in the November election.

The legislation, sponsored by Senators Terrell McKinney, Ben Hansen, and Danielle Conrad of Omaha, Blair, and Lincoln, respectively, center on setting up registry systems and outlining the Nebraska Medical Marijuana Commission’s regulating and licensing responsibilities.

The proposed bills—LB 705 (McKinney), LB 677 (Hansen), and LB 651 (Conrad)—would allow residents to acquire registry cards after obtaining a healthcare provider’s written recommendation, confirming their eligibility as a medical cannabis patient. The registry system would also cover caregivers, including those assisting minors.

Currently, the law requires the commission to finalize criteria for approving or denying applications for marijuana businesses by July 1, with licensing anticipated to begin by October 1. However, the new proposals suggest delaying the licensing process until January 1, 2026, to allow more time for regulatory preparations.

A separate proposal, LB 483, introduced by Senator Jared Storm (David City) aims to restrict the amount of delta-9 THC that can be used for medical purposes to 300 milligrams and only permit the use of liquid tinctures or pills. This restriction significantly narrows the scope compared to what voters had approved, which was overwhelmingly supported in the recent ballot measures.

Senator Conrad noted that some patients cannot consume cannabis in pill form due to medical conditions, prompting her to draft a more expansive bill to align with voters’ wishes. Senator Hansen highlighted his commitment to honoring the people’s will, citing his previous work with Senator Anna Wishart on similar efforts.

The voter-approved measures remain under legal scrutiny, with challenges still pending in state and federal courts. Attorney General Mike Hilgers and Governor Jim Pillen have raised concerns about conflicts with federal law, which classifies cannabis as a Schedule I substance. Conrad dismissed this as a political viewpoint, arguing that states have considerable authority under the Constitution to create such programs.

The measures from Hansen, McKinney, and Conrad include protection from arrest for caregivers, patients, and officials involved in medical cannabis. They would legalize medical cannabis use for patients, allowing up to 5 ounces, with exceptions for higher quantities based on a physician’s recommendation.

Each bill outlines licensing structures and fees. Conrad’s plan features five license categories: testing facility, cultivator, product manufacturer, dispensary, and vertically integrated businesses. Hansen’s bill adds a transporter license. McKinney introduces tiers for businesses—micro, small, and large-scale—and reserves over half of the licenses for social equity candidates from communities disproportionately affected by drug policies.

Tax revenue from cannabis sales would be redirected differently under each bill. Hansen prioritizes property tax relief, while McKinney and Conrad propose reinvesting funds into the cannabis program. McKinney’s plan also includes automatic expungement for specific marijuana-related offenses.

Changes or revisions to these laws need a supermajority vote in the legislature since they are the result of initiatives that were passed by the electorate. The provisions will be self-enforcing if legislators do nothing, guaranteeing that they are implemented as intended.

When the program is finally launched, numerous business opportunities will become available in the state, including for companies operating like Innovative Industrial Properties Inc. (NYSE: IIPR) that have found a niche in serving marijuana companies.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — President Trump to Play Pivotal Role in Marijuana Policy Reform and Rescheduling

With cannabis rescheduling currently on hold indefinitely, the $32 billion industry’s fate hinges on critical decisions—particularly President Donald Trump’s choice of the next Drug Enforcement Administration (DEA) director.

Trump made waves in September by becoming the first presidential candidate from a major party to support a state-level recreational marijuana legalization ballot initiative. However, since then, the topic has not resurfaced in his agenda. It also remained absent during the confirmation hearings for his attorney general nominee, Pam Bondi.

In this information vacuum, speculation has emerged based on Bondi’s record and Trump’s posts on Truth Social. A notable detail is Bondi’s time as a lobbyist for Ballard Partners, a D.C.-based company. Ballard’s client list includes Trulieve Cannabis Corp., a multistate cannabis operator based in Tallahassee, Florida, though Bondi herself is not listed as a lobbyist for the company.

Trulieve’s CEO, Kim Rivers, attended Trump’s inauguration alongside Cresco Labs CEO Charlie Bachtell. Following the event, Rivers shared on X that she had productive discussions on cannabis reform and rescheduling, calling it “a new day” for the industry.

If confirmed, Bondi’s actions—along with Trump’s choice for DEA leadership—could shape the future of cannabis reform. This urgency has heightened after DEA judge John Mulrooney II halted the administrative process to move cannabis to Schedule III. Mulrooney’s January 13 order stopped hearings that were supposed to resume on January 21, citing a request to disqualify DEA director Anne Milgram due to allegations of bias against the process.

Rescheduling would significantly relieve the cannabis sector, allowing businesses to claim standard federal tax deductions currently prohibited under federal law. However, the timing and continuation of the rescheduling hearings remain uncertain. As Mulrooney noted in his order, he could recommend restarting the entire process, but any decision ultimately rests with the next DEA director.

Trump’s first nominee for DEA leadership, Chad Chronister, withdrew his name shortly after being nominated. Trump later claimed he had withdrawn the nomination himself. Observers believe Trump might select someone with deep ties to the DEA, and this seemed likely when Derek Maltz, a long-time DEA official and opponent of rescheduling cannabis, was appointed interim administrator.

Whether Maltz becomes the next director or serves temporarily, many doubt a Trump appointee would oppose his policy stance. Similarly, the GOP-controlled Congress is unlikely to challenge Trump’s directives, despite cannabis advocates’ efforts to push reform.

Under Biden, marijuana reform efforts stalled, including a Senate bill for banking protections that never reached a full vote. Blame for this failure varies, with some pointing fingers at the Republican opposition, while others blame Chuck Schumer, the former Senate Majority Leader. Speaker of the House Mike Johnson and Senate Majority Leader John Thune are not seen as advocates for cannabis reform.

Should the Trump administration prioritize rescheduling, it could drastically alter the trajectory of marijuana policy in the United States. All the eyes of marijuana industry actors like Curaleaf Holdings Inc. (CSE: CURA) (OTCQX: CURLF) will be on the new team in Washington, D.C. to see what decisions they make and how those decisions shape the future of the industry.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Arkansas Governor Says Medical Cannabis Taxes Will Help Feed Children

Gov. Sarah Huckabee Sanders of Arkansas recently highlighted the advantages of medical cannabis tax revenue in her last week’s State of the State address, announcing a significant plan.

The state approved medical cannabis through a voter-supported amendment in 2016, but it wasn’t made available to qualifying patients until May 2019. Since then, the program has seen significant growth, with nearly 109,000 active medical cannabis ID cardholders recorded at the end of 2024.

In Arkansas, medical cannabis purchases are subject to a 4 percent privilege tax and a 6.5 percent state sales tax. The revenue collected through the sales tax contributes to important public services, such as addressing food insecurity and supporting public schools. In 2024 alone, these taxes brought in $28.5 million, increasing the medical cannabis program’s total revenue to approximately $150 million since its inception.

During her address, Sanders highlighted how the funding will be utilized. She stated:

“This year, Arkansas will join the Summer Electronic Benefit Transfer (EBT) program. Today, I’m sharing plans to allocate medical cannabis funds to ensure financial stability for the Summer EBT program and to sustain our free breakfast and lunch initiatives in the long term. Additionally, these funds will allow us to offer free school breakfasts throughout the state of Arkansas.”

Gov. Sanders’s proposal is particularly noteworthy given her history of opposing broader marijuana reforms, including her stance against a measure that sought to expand the state’s cannabis program. Despite her prior resistance to recreational cannabis legalization, the governor appears committed to preserving and enhancing the existing framework. The governor even signed legislation in 2023 allowing medical cannabis patients to obtain licenses for carrying firearms.

The National School Lunch Program, a federally supported initiative, provides assistance to almost 100,000 public and not-for-profit private schools, as well as residential childcare facilities across the United States. The program offers free meals to children from households earning less than 130% of the federal poverty level. Families with incomes between 130% and 185% of the federal poverty level can access reduced-cost meals, while those above this range pay the full price but still receive some subsidies.

Despite these efforts, many children lose access to these meals during summer breaks. The Summer EBT program, introduced in 2023 by Congress, addresses this issue by offering food assistance to low-income households during the summer months when school-provided meals are unavailable.

Marijuana enterprises like Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) will be pleased that different communities in different jurisdictions are reaping the benefits of legalizing marijuana and allowing licensed companies to impact not just patients but other sections of the population as well.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — US Border Patrol Asks Court to Dismiss Businesses’ Lawsuit on Marijuana Seizures in New Mexico

The U.S. Customs and Border Protection (CBP) and Department of Homeland Security (DHS) are asking a federal judge to dismiss a case brought by New Mexico-licensed cannabis businesses. The businesses allege that the agencies unlawfully seized state-regulated cannabis products and arrested staff members at checkpoints within the state.

According to CBP and DHS, federal law takes precedence over state law as long as cannabis remains prohibited at the federal level. They argue that border agents are authorized to disregard state regulations and seize cannabis products. Furthermore, they assert that protections afforded to state cannabis programs through the Department of Justice (DOJ) policies and congressional rider do not extend to CBP, which operates under DHS.

The lawsuit, brought by 8 New Mexico cannabis businesses, was filed in October last year after reports surfaced of CBP agents seizing products and other property from state-licensed cannabis businesses at border checkpoints across New Mexico.

The businesses claim these actions violate the Fifth Amendment by conducting seizures and searches without following proper procedures. CBP has countered this argument, requesting the case be dismissed on grounds of insufficient claims and lack of jurisdiction.

The lawsuit further describes incidents where CBP detained cannabis business employees for extended periods without filing charges. Although CBP did not directly address these detentions, it maintained its authority to detain individuals under current federal law.

The agency also addressed specific complaints, such as the seizure of non-marijuana property assets like vehicles and cash. CBP argued that since the vehicles were returned to the plaintiffs before the lawsuit was filed, the issue is moot, and the plaintiffs lack standing to seek further relief.

In response to allegations that their actions contradict federal regulations and policy precedents, CBP emphasized that protections for state cannabis programs only apply to the DOJ under a congressional rider and do not extend to DHS or its agencies. Additionally, they rejected claims that prior Treasury Department or DOJ guidance on cannabis reform has any legal bearing, stating that federal law continues to prohibit cannabis and provides no exceptions for CBP or DHS to stop enforcing those restrictions. CBP and DHS also reiterated that cannabis is still classified as a Schedule 1 substance under the CSA.

The plaintiffs are asking the court to require CBP to provide documentation of seized property, return the items or compensate them for their value, and establish a process to contest future seizures in compliance with the Fifth Amendment.

The issue has also drawn attention from legislators, with Representative Gabe Vasquez proposing an amendment to appropriations legislation for DHS, aiming to restrict border agents from using federal funds to confiscate cannabis products from state-licensed operators.

The marijuana industry and its leading firms like Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) will be hoping that the court system clears the air on whether it is acceptable for Border Patrol to seize cannabis products from licensed companies that are conducting their legitimate business activities in states bordering neighboring countries.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Activists in Florida File New Initiative to Legalize Recreational Marijuana

Marijuana advocates in Florida have submitted a fresh proposal aimed at legalizing recreational cannabis. The new measure comes only two months after a similar one failed to secure the required supermajority vote during the November election. Florida residents will have the opportunity to vote on the legalization of recreational cannabis in 2026 if the measure is approved.

Smart and Safe Florida, the group behind the measure, officially submitted it to the state Elections’ Division on Tuesday. The initiative would legalize recreational cannabis use for individuals 21 years of age or older while establishing regulations for the cultivation, sale, and distribution of marijuana. Under the proposed rules, adults would be allowed to possess a maximum of five grams of cannabis concentrates and two ounces of marijuana.

The revised initiative introduces significant changes compared to last year’s ballot measure to address criticisms that contributed to its failure. One key concern, voiced by Republican Governor Ron DeSantis, was that the previous measure would have limited the state legislature’s ability to regulate where marijuana could be consumed.

To address this, the updated proposal explicitly bans vaping and smoking cannabis in public spaces. Additionally, it includes provisions to prevent marijuana packaging and advertising from appealing to children.

Another notable addition to the new initiative is a clause allowing the legislature to authorize adults to grow cannabis at home for personal use under reasonable regulations. This addresses a criticism of the previous proposal, which lacked provisions for home cultivation—a feature many marijuana reform advocates had hoped to see.

The previous attempt to legalize cannabis, Amendment 3, was backed by about 56% of voters in the general election held in November. But it didn’t reach the 60% threshold that Florida law requires. The unsuccessful measure was heavily backed by Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF), the largest supplier of medical cannabis in the state.

Similar to Amendment 3, the latest proposal would permit Florida’s existing medical marijuana businesses to expand into the recreational market, allowing sales to individuals 21 years of age and older. It also requires issuing new licenses to businesses exclusively focused on recreational cannabis.

To qualify for the ballot, Smart and Safe Florida must collect approximately 900,000 valid voters’ signatures. Should the necessary signatures be obtained and the language of the measure be approved by Florida’s Supreme Court, voters will have the opportunity to decide on the proposal in 2026.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Marijuana is Widely Available in Texas Despite its Prohibitive Laws

In Texas, getting high has never been easier, despite the state’s reputation for strict policies and socially conservative values. While recreational cannabis remains illegal, Texas boasts over 7,000 marijuana dispensaries—nearly double the number in California. The market has expanded to include 24/7 marijuana delivery services, mobile dispensary trucks, vending machines, and even mail-order options.

The contradiction arises from the state legislature, which has consistently opposed legalizing recreational cannabis. Yet, due to a rapidly growing and loosely regulated hemp market, Texas has unintentionally earned the nickname “the THC Republic.”

It began when Congress passed Farm Bill 2018, which legalized hemp by classifying it separately from cannabis. While cannabis contains high levels of THC, hemp has significantly lower levels. In 2019, Texas followed suit by allowing farmers to grow hemp for uses like textiles, paper, and clothing. Legislators believed they were steering clear of legalizing cannabis. However, a loophole in the hemp law enabled the sale of potent cannabis products.

Texas isn’t alone—eleven other states, primarily in the South, have experienced similar unintended consequences after passing hemp-friendly legislation. However, with its large cities and rapidly growing population, Texas has become the center of this trend. Although medical cannabis is legal in Texas, it’s tightly regulated, expensive, and limited to certain conditions like multiple sclerosis and cancer.

The largely unregulated hemp market has grown far beyond medical cannabis, creating significant challenges. Without age restrictions, some shops sell hemp products to underage buyers, including students after school hours. Moreover, licensed medical cannabis providers face difficulty competing with the hemp industry, which operates with fewer restrictions and a dedicated customer base.

Interestingly, the hemp market has also led to a dramatic decrease in the cannabis black market. Seizures of illegal cannabis along the Southwest border decreased by 72% between 2021 and 2023. Consumers now prefer regulated cannabis over the harsher, cartel-supplied “brickweed.”

In places like El Paso, residents who previously relied on dealers from Juarez, Mexico, can now cross into nearby New Mexico, where recreational cannabis has been legal since 2021, to shop at upscale dispensaries.

Psychoactive hemp will be a high agenda item when the Texas legislature meets for its biennial session. While the marijuana industry hopes for more mild rules, Gov. Dan Patrick has pledged to advocate for a total prohibition of THC products. If successful, it could mark the end of Texas’ thriving THC marketplace.

The broader marijuana industry, including Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF), will be following the developments in Texas to see how the legitimate needs of residents who wish to consume THC products will be addressed by the conservative lawmakers in the state.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Illinois OKs Additional Conditions for Which Women Can Use Medical Marijuana

Cannabis regulators in Illinois have expanded the list of qualifying conditions for medical marijuana for the first time since legalization in 2019, focusing specifically on women’s health issues.

The state’s public health department, following recommendations from the Medical Cannabis Advisory Board, approved four new conditions: female orgasmic disorder, uterine fibroids, ovarian cysts, and endometriosis.

While cannabis cannot shrink cysts or fibroids as some treatments might, it can help alleviate the pain brought by these conditions, explained Doctor Leslie Mendoza Temple, co-chair of the advisory board. She expressed satisfaction with the state’s decision to approve the conditions after nearly six years without any additions to the list, despite previous recommendations.

Currently, Illinois allows medical marijuana for 56 conditions, including chronic pain, cancer, multiple sclerosis, terminal illnesses, and osteoarthritis. Doctors can recommend marijuana to patients with these qualifying conditions, enabling them to obtain a medical marijuana card.

The card requires a $50 yearly charge and a doctor’s certification and allows patients to purchase marijuana from licensed dispensaries without paying the steep recreational marijuana tax, which can be as high as 45 percent.

Although recreational marijuana is legally available to adults 21 and older, Dr. Mendoza Temple emphasized the importance of maintaining a distinction between medical and recreational use. Beyond cost savings, medical patients and their caregivers can purchase up to 2.5 ounces at once—compared to one ounce for adult-use buyers—and are also permitted to grow up to five cannabis plants.

Dr. Mendoza Temple also highlighted areas where the medical program could be improved, such as permitting drive-through cannabis sales, increasing the number of dispensaries authorized to sell medical cannabis, and granting broader access to all licensed dispensaries in Illinois.

Regulators have acknowledged these concerns and are working on legislation to enhance patient access statewide.

Among the newly approved conditions, endometriosis involves tissue resembling the uterine lining growing outside the uterus, often causing scarring, severe pain, and potential infertility. Female orgasmic disorder refers to difficulties in achieving orgasm, which can stem from various underlying causes. According to the IDPH, evidence suggests marijuana may provide relief for both conditions.

“Medical marijuana has demonstrated its effectiveness in managing symptoms of numerous debilitating conditions,” stated Dr. Sameer Vohra, director of IDPH. He added that the department thoroughly evaluates petitions using professional analysis and the latest scientific evidence to make informed decisions for the well-being of Illinois residents.

Leading entities like Tilray Brands Inc. (NASDAQ: TLRY) (TSX: TLRY) that offer medical cannabis are likely to applaud the decision of the Illinois authorities to expand the list of qualifying conditions so that more patients can benefit from the medical marijuana program.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Observers Say Budgetary Pressures Could Boost Efforts to Legalize Marijuana in Iowa

A significant portion of adults in the U.S. remains in favor of cannabis legalization. However, despite this momentum, three out of four recreational legalization initiatives—proposed in Florida, South Dakota, and North Dakota—failed during the November elections.

Projections indicate that about five states might legalize cannabis this year, though Iowa appears to be an exception. As with many policy matters, expanding access to medical marijuana or legalizing recreational marijuana sales in Iowa involves multiple layers of complexity. Issues such as health, social justice, law enforcement, economic impact, agriculture, and employment are all intertwined in this debate.

Observers note that financial considerations may ultimately drive change. Iowa has drastically reduced its tax rates and state spending while increasing costs for programs like private school tuition vouchers. This fiscal pressure could lead to the pursuit of new revenue streams, with cannabis taxes being a plausible option.

Former Iowa deputy treasurer Mike Tramontina called the state’s budgetary strategy unsustainable. He noted that while the state’s finances have been strengthened by federal aid and a robust economy, significant cuts to support for natural resources, public education, and regulatory supervision have been excessive.

Spending on private school vouchers has also increased dramatically, rising from $106.9 million in 2023–2024 to an estimated $179.2 million in 2024–2025. Most of the funds, critics say, go to richer families whose kids are already enrolled in private schools.

Tramontina predicts that the state will require $40 million to $50 million in additional revenue soon. He suggests that legalizing cannabis might become a viable solution given the limited revenue potential of Iowa’s current medical cannabis program.

Meanwhile, Iowans looking to purchase cannabis legally often travel to neighboring states like Missouri, Illinois, or Minnesota, boosting their economies instead. Illinois, for example, reported that Wisconsin residents spent $36.1 million on marijuana there in 2022, generating over $3.6 million in tax revenue.

Despite growing public support—approximately 60% of Iowans favor legalization—political resistance remains strong. Republican lawmakers in Iowa have consistently blocked Democratic-led cannabis legislation, including a 2023 proposal to decriminalize cannabis and expunge records for possession offenses.

Meanwhile, opponents, including Representative Ann Meyer, cite concerns over the potential impact on brain development and youth access. Still, there is bipartisan acknowledgment of the medical benefits of cannabis. For example, Meyer has noted its effectiveness in treating conditions like seizures and PTSD. Similarly, pharmacist and former legislator John Forbes supports medical cannabis as a safer alternative to opioids for pain management.

As in many states, Iowa’s debate over cannabis legalization remains contentious. While public sentiment appears to favor change, legislative hurdles suggest a lengthy battle ahead. Eventually, the fiscal and other benefits that other jurisdictions where companies like SNDL Inc. (NASDAQ: SNDL) operate have witnessed could turn around the opposition and give reform a chance.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com